These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 28887119

  • 1. Respiratory syncytial virus associated hospitalizations in children with congenital diaphragmatic hernia.
    Resch B, Liziczai K, Reiterer F, Freidl T, Haim M, Urlesberger B.
    Pediatr Neonatol; 2018 Apr; 59(2):184-188. PubMed ID: 28887119
    [Abstract] [Full Text] [Related]

  • 2. Respiratory Syncytial Virus Prophylaxis in Infants With Congenital Diaphragmatic Hernia in the Canadian Respiratory Syncytial Virus Evaluation Study of Palivizumab, 2005-2017.
    Kim D, Saleem M, Paes B, Mitchell I, Lanctôt KL.
    Clin Infect Dis; 2019 Aug 30; 69(6):980-986. PubMed ID: 30517603
    [Abstract] [Full Text] [Related]

  • 3. Respiratory syncytial virus bronchiolitis in congenital diaphragmatic hernia: A systematic review of prevalence rates and palivizumab prophylaxis.
    Lewis L, Sinha I, Losty PD.
    Pediatr Pulmonol; 2022 Jan 30; 57(1):239-244. PubMed ID: 34617409
    [Abstract] [Full Text] [Related]

  • 4. Respiratory syncytial virus hospitalizations in infants of 28 weeks gestational age and less in the palivizumab era.
    Resch B, Egger B, Kurath-Koller S, Urlesberger B.
    Int J Infect Dis; 2017 Apr 30; 57():50-53. PubMed ID: 28163166
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-2017 epidemic season: a systematic review of seven Italian reports.
    Cutrera R, Wolfler A, Picone S, Rossi GA, Gualberti G, Merolla R, Del Vecchio A, Villani A, Midulla F, Dotta A.
    Ital J Pediatr; 2019 Nov 09; 45(1):139. PubMed ID: 31706338
    [Abstract] [Full Text] [Related]

  • 7. Respiratory Syncytial Virus Infection-associated Hospitalization Rates in Infants and Children With Cystic Fibrosis.
    Metz J, Eber E, Resch B.
    Pediatr Infect Dis J; 2017 Jun 09; 36(6):545-548. PubMed ID: 28005688
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk of respiratory syncytial virus in survivors with severe congenital diaphragmatic hernia.
    Masumoto K, Nagata K, Uesugi T, Yamada T, Kinjo T, Hikino S, Hara T, Taguchi T.
    Pediatr Int; 2008 Aug 09; 50(4):459-63. PubMed ID: 19143967
    [Abstract] [Full Text] [Related]

  • 14. Palivizumab use in infants with Down syndrome-report from the German Synagis™ Registry 2009-2016.
    Simon A, Gehrmann S, Wagenpfeil G, Wagenpfeil S.
    Eur J Pediatr; 2018 Jun 09; 177(6):903-911. PubMed ID: 29651734
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
    Hashmi NA, Cosgrove JF, MacMahon P.
    Ir Med J; 2000 Dec 09; 93(9):284. PubMed ID: 11209917
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cost Savings Without Increased Risk of Respiratory Hospitalization for Preterm Children after the 2014 Palivizumab Policy Update.
    Levin JC, Beam AL, Fox KP, Hayden LP.
    Am J Perinatol; 2024 May 09; 41(S 01):e133-e141. PubMed ID: 35523410
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.